We intend to capitalize on our management team’s differentiated ability to source, acquire, and manage a business in the healthcare industry, specifically healthcare services, healthcare information technology, care management, behavioral health, medical devices, diagnostics, pharma services, health and wellness, and specialty pharmacy.

(Note: CA Healthcare Acquisition priced its IPO on Jan. 26, 2021, according to the terms in the prospectus: 10 million units at $10 to raise $100 million. On April 7, 2021, CA Healthcare Acquisition announced that it had entered into a definitive agreement to combine with LumiraDx, a COVID-19 testing company and medical device maker, in a deal with an enterprise value of $5 billion. LumiraDx withdrew its IPO on or about April 7, 2021.)